Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 15/20 | 0.90 |
| ▸ | FNTB | P49356 | 15/20 | 0.90 |
| ▸ | PGGT1B | P53609 | 7/20 | 0.90 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5084894 | 1.00 | FNTA (0.90) | FNTAFNTBPGGT1BTDP1 | |
| Trifluoroacetic Acid SCHEMBL29394662 | 1.00 | FNTA (0.90) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL2722114 | 0.95 | FNTA (1.00) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL4148121 | 0.95 | FNTA (1.00) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL16111993 | 0.95 | FNTA (1.00) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL8492288 | 0.95 | FNTA (1.00) | FNTAFNTBPGGT1BTDP1 | |
| SCHEMBL17534949 | 0.95 | FNTA (1.00) | FNTAFNTBPGGT1BTDP1 | |
| Trifluoroacetic Acid SCHEMBL5078478 | 0.93 | FNTA (0.90) | FNTAFNTBPGGT1BTDP1 | |
| Trifluoroacetic Acid SCHEMBL5078474 | 0.93 | FNTA (0.90) | FNTAFNTBPGGT1BTDP1 | |
| Trifluoroacetic Acid SCHEMBL29395402 | 0.93 | FNTA (0.90) | FNTAFNTBPGGT1BTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106667988-A | Application of farnesyltransferase inhibitors in preparation of medicine for facilitated cholinergic nerve system | 南京医科大学 | 2017-05-17 | — | — | CN | disclosed |
| US-20080139457-A1 | Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2008-06-12 | — | — | US | disclosed |
| WO-2007035395-A9 | THERAPEUTIC COMPOSITIONS COMPRISING CHORIONIC GONADOTROPINS AND HMG COA REDUCTASE INHIBITORS | UNIV VIRGINIA COMMONWEALTH (US) | 2007-06-14 | — | — | WO | disclosed |
| WO-2007035395-A2 | THERAPEUTIC COMPOSITIONS COMPRISING CHORIONIC GONADOTROPINS AND HMG COA REDUCTASE INHIBITORS | VIRGINIA COMMONWEALTH UNIVERSITY INTELLECTUAL PROPERTY FOUNDATION (US) | 2007-03-29 | — | — | WO | disclosed |